NCT05255185Completed

Domino Therapy Treat the Infection Around the Prosthesis After the Limb Salvage Surgery of Bone Tumor

Name: Clinical Trial NCT05255185
Creator: Second Affiliated Hospital, School of Medicine, Zhejiang University
Keywords: Infection, domino therapy, procedure, clinical trial, China

Can Domino Therapy Effectively Treat the Infection Around the Prosthesis After the Limb Salvage Surgery of Bone Tumor？-----A Study of Sequential Therapy

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityClinicalTrials.govprocedure

Verified

Study focus

Disease/Condition: Infection
Drug/Device/Intervention: domino therapy
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Location: Hangzhou, China

Timeline & enrollment

Phase: N/A
Start date: Aug 01, 2017
End date: Oct 01, 2021
Enrollment: 14 participants

Primary outcome

success rate of patients undergoing domino therapy assessed by MSIS diagnostic criteria

Summary

Tumor resection and prosthetic replacement have become the treatments of choice for malignant bone tumors. Infections are the main cause of failure of limb salvage surgeries. Therefore, treatment of infections around prostheses after limb salvage is important, but is also challenging. Our research team designed a domino sequential treatment plan to treat postoperative infections around tumor prostheses and evaluated its efficacy.

ICD-10 classifications

Bacterial infection, unspecifiedBacterial, viral and other infectious agentsInfection following immunizationOther infectious diseasesViral infection, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05255185
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05255185 through Pure Global AI's free database. This phase not specified trial is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University and is currently Completed. The study focuses on Infection. Target enrollment is 14 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.